Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, ...
Over 400 enforcement actions, including show cause notices, production stoppages, and license cancellations, have been taken ...
美国 FDA 发布2025 年第一份指南草案,题为“遵循 21 CFR 211.110 的考量因素”,协助制药商遵守这一章节的法规条款,以确保批次一致性和药品可靠性。
Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new facilities, strategically positioned across key global markets ...
The FDA's Good Manufacturing Practice (GMP) regulations provide a framework of essential requirements for the methods, facilities and controls used in manufacturing, processing and packaging of a drug ...
The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...
Kenox Pharmaceuticals Inc., a company dedicated to developing innovative Orally Inhaled and Nasal Drug Products (OINDPs), has ...
It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response in patients, however, there has recently been an increased demand for type O female blood-derived iPSCs.